[1] Hingorani M, Hanson I, van Heyningen V. Aniridia[J]. Eur J Hum Genet,2012,20(10):1011-1017. [2] Lee H, Khan R, O'Keefe M. Aniridia: current pathology and management[J]. Acta Ophthalmol,2008,86(7):708-715. [3] Grønskov K, Olsen JH, Sand A, et al.Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia[J]. Hum Genet,2001,109(1):11-18. [4] Bhatia S, Bengani H, Fish M, et al.Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia[J]. Am J Hum Genet,2013,93(6):1126-1134. [5] Zhang X, Qin G, Chen G, et al.Variants in TRIM44 cause aniridia by impairing PAX6 expression[J]. Hum Mutat,2015,36(12):1164-1167. [6] Brémond-Gignac D, Bitoun P, Reis LM, et al.Identification of dominant FOXE3 and PAX6 mutations in patients with congenital cataract and aniridia[J]. Mol Vis,2010,16:1705-1711. [7] Fischbach BV, Trout KL, Lewis J, et al.WAGR syndrome: a clinical review of 54 cases[J]. Pediatrics,2005, 116(4):984-988. [8] Gerber S, Alzayady KJ, Burglen L, et al.Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome[J]. Am J Hum Genet,2016,98(5):971-80. [9] Richards S, Aziz N, Bale S, et al.Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med,2015,17(5):405-424. [10] Ton CC, Hirvonen H, Miwa H, et al.Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region[J]. Cell,1991,67(6):1059-1074. [11] Tzoulaki I, White IM, Hanson IM.PAX6 mutations: genotype-phenotype correlations[J]. BMC Genet,2005,6:27. [12] Cvekl A, Callaerts P. PAX6: 25th anniversary and more to learn[J/OL]. Exp Eye Res,2016-04-25[2017-02-20].http://www.sciencedirect.com/science/article/pii/S0014483516300902 |